TRISALUS LIFE SCIENCES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.72 USD | -3.38% |
|
-0.87% | -32.31% |
| 06-03 | TriSalus Life Sciences, Inc. Highlights Clinical Data from Phase 1b Perio-02 Trial | CI |
| 05-30 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |
Quotes 5-day view
End-of-day quote Nasdaq| 2024-06-14 | 2024-06-17 | 2024-06-18 | 2024-06-20 | 2024-06-21 | |
|---|---|---|---|---|---|
| Last | 5.77 $ | 5.92 $ | 5.72 $ | 5.68 $ | 5.69 $ |
| Volume | 23 706 | 24 528 | 39 045 | 46 571 | 33 531 |
| Change | -1.03% | +2.60% | -3.38% | -0.70% | +0.18% |
| Opening | 5.83 | 5.68 | 5.91 | 5.61 | 5.61 |
| High | 6.18 | 6.14 | 5.91 | 5.89 | 6.08 |
| Low | 5.77 | 5.68 | 5.67 | 5.61 | 5.61 |
Performance
| 1 day | -3.38% | ||
| 1 week | -0.87% | ||
| Current month | -20.11% | ||
| 1 month | -40.91% | ||
| 3 months | -41.51% | ||
| 6 months | -34.63% | ||
| Current year | -32.31% | ||
| 1 year | -45.42% | ||
| 3 years | -42.11% |
Volumes
marketsDaily volume
39 045
Avg. Volume 20 sessions
35 528
Avg. Volume 20 sessions USD
203 220.16
Record volume 1
5 431 029
Record volume 2
3 261 793
Record volume 3
1 366 900
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
154 536 570
Net sales (USD)
18 511 000
Number of employees
101
Sales / Employee (USD)
183 277
Free-Float
46.5 %
Free-Float capitalization (USD)
71 852 643
Average Daily Capital Traded
0.13%
Highs and lows
1 week
5.61
6.14
1 month
5.619.00
Current year
5.6110.42
1 year
3.3216.24
3 years
3.3216.24
5 years
3.3216.24
10 years
3.3216.24
Indicators
Moving average 5 days
5.85
Moving average 20 days
7.18
Moving average 50 days
8.70
Moving average 100 days
9.09
Price spread / (MMA5)
+2.27%
Price spread / (MMA20)
+25.52%
Price spread / (MMA50)
+52.10%
Price spread / (MMA100)
+58.92%
STIM
RSI 9 days
21.02
RSI 14 days
24.12
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -3.38% | -0.87% | -32.31% | -45.42% | 155M | ||
| -0.57% | -2.50% | +15.19% | +34.62% | 121B | ||
| +0.84% | +1.60% | +19.91% | +35.05% | 114B | ||
| +3.65% | +3.02% | +8.24% | +2.40% | 23.61B | ||
| -1.44% | -8.08% | -19.80% | -21.13% | 20.43B | ||
| +0.50% | -1.45% | -16.19% | -30.65% | 16.55B | ||
| +0.37% | -3.98% | -13.45% | -16.03% | 16.45B | ||
| -1.46% | -7.35% | -44.35% | -36.03% | 15.59B | ||
| +30.14% | +30.84% | +66.67% | +29.70% | 15.19B | ||
| +0.37% | -0.65% | +2.13% | +37.53% | 13.54B | ||
| +5.07% | +6.37% | +119.39% | +234.27% | 10.96B | ||
| +3.00% | +2.74% | +19.33% | +38.60% | 8.15B | ||
| +4.44% | +0.38% | -29.18% | -43.19% | 7.77B | ||
| -0.07% | +0.28% | -1.77% | +24.74% | 7.59B | ||
| +5.12% | +0.16% | +1.51% | +43.86% | 7.33B | ||
| +18.62% | +15.85% | +105.65% | +178.69% | 6.85B | ||
| Average | +4.08% | +1.97% | +12.56% | +29.19% | ||
| Weighted average by Cap. | +2.02% | +0.59% | +14.10% | +28.90% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -32.66% | ||
| 2023 | -15.75% | ||
| 2022 | +1.52% | ||
| 2021 | -6.08% |
- Stock Market
- Equities
- TLSI Stock
- Quotes TriSalus Life Sciences, Inc.
